These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 16271804)

  • 21. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.
    Kanninen K; Goldsteins G; Auriola S; Alafuzoff I; Koistinaho J
    Neurosci Lett; 2004 Sep; 367(2):235-40. PubMed ID: 15331161
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
    Castegna A; Aksenov M; Aksenova M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
    Free Radic Biol Med; 2002 Aug; 33(4):562-71. PubMed ID: 12160938
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease.
    Choi J; Forster MJ; McDonald SR; Weintraub ST; Carroll CA; Gracy RW
    Free Radic Biol Med; 2004 May; 36(9):1155-62. PubMed ID: 15082069
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PP2A mRNA expression is quantitatively decreased in Alzheimer's disease hippocampus.
    Vogelsberg-Ragaglia V; Schuck T; Trojanowski JQ; Lee VM
    Exp Neurol; 2001 Apr; 168(2):402-12. PubMed ID: 11259128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage.
    Shen L; Chen C; Yang A; Chen Y; Liu Q; Ni J
    J Proteomics; 2015 Jun; 123():101-13. PubMed ID: 25890254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of zinc transporters-4 and -6 in mild cognitive impairment, early and late Alzheimer's disease brain.
    Smith JL; Xiong S; Markesbery WR; Lovell MA
    Neuroscience; 2006 Jul; 140(3):879-88. PubMed ID: 16580781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and differential distribution of the three major human protein kinase C isozymes (PKC alpha, PKC beta, and PKC gamma) of the central nervous system in normal and Alzheimer's disease brains.
    Clark EA; Leach KL; Trojanowski JQ; Lee VM
    Lab Invest; 1991 Jan; 64(1):35-44. PubMed ID: 1990207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxidative modification of proteins in the frontal cortex of Alzheimer's disease brain.
    Korolainen MA; Goldsteins G; Nyman TA; Alafuzoff I; Koistinaho J; Pirttilä T
    Neurobiol Aging; 2006 Jan; 27(1):42-53. PubMed ID: 16298240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics.
    Sultana R; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2006; 8(11-12):2021-37. PubMed ID: 17034347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxidized proteins in Alzheimer's plasma.
    Conrad CC; Marshall PL; Talent JM; Malakowsky CA; Choi J; Gracy RW
    Biochem Biophys Res Commun; 2000 Aug; 275(2):678-81. PubMed ID: 10964722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Altered expression of COX-2 in subdivisions of the hippocampus during aging and in Alzheimer's disease: the Hisayama Study.
    Fujimi K; Noda K; Sasaki K; Wakisaka Y; Tanizaki Y; Iida M; Kiyohara Y; Kanba S; Iwaki T
    Dement Geriatr Cogn Disord; 2007; 23(6):423-31. PubMed ID: 17457030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amyloid-dependent triosephosphate isomerase nitrotyrosination induces glycation and tau fibrillation.
    Guix FX; Ill-Raga G; Bravo R; Nakaya T; de Fabritiis G; Coma M; Miscione GP; Villà-Freixa J; Suzuki T; Fernàndez-Busquets X; Valverde MA; de Strooper B; Muñoz FJ
    Brain; 2009 May; 132(Pt 5):1335-45. PubMed ID: 19251756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of oxidized RNAs in Alzheimer's disease.
    Shan X; Lin CL
    Neurobiol Aging; 2006 May; 27(5):657-62. PubMed ID: 15979765
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense directed against PS-1 gene decreases brain oxidative markers in aged senescence accelerated mice (SAMP8) and reverses learning and memory impairment: a proteomics study.
    Fiorini A; Sultana R; Förster S; Perluigi M; Cenini G; Cini C; Cai J; Klein JB; Farr SA; Niehoff ML; Morley JE; Kumar VB; Butterfield DA
    Free Radic Biol Med; 2013 Dec; 65():1-14. PubMed ID: 23777706
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidative stress in Alzheimer's disease brain: new insights from redox proteomics.
    Butterfield DA; Perluigi M; Sultana R
    Eur J Pharmacol; 2006 Sep; 545(1):39-50. PubMed ID: 16860790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease.
    Aldred S; Bennett S; Mecocci P
    Clin Biochem; 2010 Feb; 43(3):267-71. PubMed ID: 19733555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxidative stress in the aging murine olfactory bulb: redox proteomics and cellular localization.
    Vaishnav RA; Getchell ML; Poon HF; Barnett KR; Hunter SA; Pierce WM; Klein JB; Butterfield DA; Getchell TV
    J Neurosci Res; 2007 Feb; 85(2):373-85. PubMed ID: 17131389
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Redox proteomics studies of in vivo amyloid beta-peptide animal models of Alzheimer's disease: Insight into the role of oxidative stress.
    Sultana R; Butterfield DA
    Proteomics Clin Appl; 2008 May; 2(5):685-96. PubMed ID: 21136866
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.